VASCULAR BIOGENICS LTD (VBLT) Stock Price, Quote, News and Overview

What is the stock price of VASCULAR BIOGENICS LTD today?

The current stock price of VBLT is 0.156 USD. The price decreased by -8.77% in the last trading session.

What is the ticker symbol for VASCULAR BIOGENICS LTD stock?

The exchange symbol of VASCULAR BIOGENICS LTD is VBLT and it is listed on the Nasdaq exchange.

On which exchange is VBLT stock listed?

VBLT stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for VASCULAR BIOGENICS LTD stock?

7 analysts have analysed VBLT and the average price target is 5.1 USD. This implies a price increase of 3169.23% is expected in the next year compared to the current price of 0.156. Check the VASCULAR BIOGENICS LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is VASCULAR BIOGENICS LTD worth?

VASCULAR BIOGENICS LTD (VBLT) has a market capitalization of 12.11M USD. This makes VBLT a Nano Cap stock.

How many employees does VASCULAR BIOGENICS LTD have?

VASCULAR BIOGENICS LTD (VBLT) currently has 7 employees.

What are the support and resistance levels for VASCULAR BIOGENICS LTD (VBLT) stock?

VASCULAR BIOGENICS LTD (VBLT) has a resistance level at 0.27. Check the full technical report for a detailed analysis of VBLT support and resistance levels.

Is VASCULAR BIOGENICS LTD (VBLT) expected to grow?

The Revenue of VASCULAR BIOGENICS LTD (VBLT) is expected to grow by 68.85% in the next year. Check the estimates tab for more information on the VBLT EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy VASCULAR BIOGENICS LTD (VBLT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of VBLT, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of VBLT, evaluating the profitability, health, valuation and growth aspects
• VASCULAR BIOGENICS LTD (VBLT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• VASCULAR BIOGENICS LTD (VBLT) Sales and EPS estimates to see what analysts future expectations are.
• VASCULAR BIOGENICS LTD (VBLT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• VASCULAR BIOGENICS LTD (VBLT) Insider and Institutional Ownership to learn about the owners and their transactions.
• VASCULAR BIOGENICS LTD (VBLT) Stock Chart to make your own analysis
• VASCULAR BIOGENICS LTD (VBLT) Latest news and press-releases to stay up to date.

Does VASCULAR BIOGENICS LTD (VBLT) stock pay dividends?

VBLT does not pay a dividend.

When does VASCULAR BIOGENICS LTD (VBLT) report earnings?

VASCULAR BIOGENICS LTD (VBLT) will report earnings on 2023-11-13, before the market open.

What is the Price/Earnings (PE) ratio of VASCULAR BIOGENICS LTD (VBLT)?

VASCULAR BIOGENICS LTD (VBLT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.21).

ChartMill assigns a fundamental rating of 3 / 10 to VBLT. The financial health of VBLT is average, but there are quite some concerns on its profitability.

Over the last trailing twelve months VBLT reported a non-GAAP Earnings per Share(EPS) of -0.21. The EPS increased by 56.41% compared to the year before.

ChartMill assigns a Buy % Consensus number of 46% to VBLT. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of -15.38% and a revenue growth 68.85% for VBLT